
- 304 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
About this book
Vaccine development is a complex and time consuming process that differs from the development of conventional pharmaceuticals. Primarily, vaccines are intended for use in healthy individuals as a preventative measure, requiring a long and rigorous process of research and many years of testing and development prior to clinical trials and regulatory approval. The average time for the development of vaccines to clinical is 12 to 15 years. Vaccine Development: From Concept to Clinic is a detailed overview of the development of new vaccines, covering the entire process and addresses all classes of vaccines from a processing, development and regulatory viewpoint. Utilising successful case studies the book will provide insight to the issues scientists face when producing a vaccine, the steps involved and will serve as an ideal reference tool regarding state-of-the-art vaccine development. This book is an ideal companion for any researchers working in vaccine discovery and development or with an interest in the field.
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Information
Table of contents
- Cover
- Title
- Copyright
- Contents
- Chapter 1 Vaccine Development: From Concept to Clinic
- Chapter 2 Preclinical Safety Assessment Considerations for Vaccine Development
- Chapter 3 Clinical Trials in the Development of Vaccines for Infectious Diseases
- Chapter 4 Clinical Trials in Immunotherapeutic Vaccine Development
- Chapter 5 Pathogenesis and Immunity of SARS-CoV-2 and Vaccination Programs Against COVID-19
- Chapter 6 High-throughput Assays for Clinical Development
- Chapter 7 Virus-like Particle-based Vaccines: GARDASIL®
- Chapter 8 Cell Culture-based Influenza Vaccine Development
- Chapter 9 Conjugate Vaccines: Design and Development Considerations
- Chapter 10 Vaccine Adjuvants: Mechanisms of Action
- Chapter 11 Development Considerations for Final Dosage Forms: Mucosal Bacterial Vaccines
- Chapter 12 Exploiting Glycans in Vaccine Design
- Chapter 13 The PATH Experience in Vaccine Development Partnerships with Manufacturers from Emerging Markets
- Subject Index